Recursion Pharmaceuticals
RXRX
#5082
Rank
$1.76 B
Marketcap
$2.82
Share price
3.86%
Change (1 day)
-32.09%
Change (1 year)

Earnings for Recursion Pharmaceuticals (RXRX)

Earnings in 2026 (TTM): -$0.48 Billion USD

According to Recursion Pharmaceuticals's latest financial reports the company's current earnings are $67.01 Million USD. In 2025 the company made an earning of -$0.65 Billion USD a decrease over its 2024 earnings that were of -$0.47 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Recursion Pharmaceuticals from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$0.48 Billion-25.47%
2025 -$0.65 Billion38.83%
2024 -$0.47 Billion39.51%
2023 -$0.34 Billion38.68%
2022 -$0.24 Billion30.46%
2021 -$0.19 Billion114.28%
2020 -$85.65 Million